Discover how metabolomics can advance your drug discovery program
The Pharmaceutical and Biotech industry utilizes metabolomics in a number of key areas in their drug research and development pipelines.
- Pre-clinical use of cell lines
- Bioassays and animal models use metabolomics to validate target engagement,
- Search for markers of disease progression
- and much more…
Clinical studies use retroactive/prospective samples from biorepositories or from on-going clinical studies with metabolomic profiles to help find early biomarkers of disease or understand patient stratification.
Metabolomics Platform with Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Plasma Analysis
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study